252 related articles for article (PubMed ID: 16278617)
1. Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?
Lau CB; Ho TC; Chan TW; Kim SC
Menopause; 2005; 12(6):734-40. PubMed ID: 16278617
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms.
Amato P; Christophe S; Mellon PL
Menopause; 2002; 9(2):145-50. PubMed ID: 11875334
[TBL] [Abstract][Full Text] [Related]
3. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation.
Bodinet C; Freudenstein J
Menopause; 2004; 11(3):281-9. PubMed ID: 15167307
[TBL] [Abstract][Full Text] [Related]
4. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
[TBL] [Abstract][Full Text] [Related]
5. The growth inhibitory activity of the Cimicifuga racemosa extract Ze 450 is mediated through estrogen and progesterone receptors-independent pathways.
Garita-Hernandez M; Calzado MA; Caballero FJ; Macho A; Muñoz E; Meier B; Brattström A; Fiebich BL; Appel K
Planta Med; 2006 Mar; 72(4):317-23. PubMed ID: 16557472
[TBL] [Abstract][Full Text] [Related]
6. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journe F; Chaboteaux C; Magne N; Duvillier H; Laurent G; Body JJ
Breast Cancer Res; 2006; 8(1):R2. PubMed ID: 16417650
[TBL] [Abstract][Full Text] [Related]
7. Dong Quai (Angelica sinensis).
J Soc Integr Oncol; 2009; 7(3):121-2. PubMed ID: 19706236
[No Abstract] [Full Text] [Related]
8. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
Takei H; Lee ES; Jordan VC
Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
[TBL] [Abstract][Full Text] [Related]
9. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.
Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS
In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835
[TBL] [Abstract][Full Text] [Related]
10. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenic risk of Angelica sinensis on ER-positive breast cancer growth through ER-induced stemness in vitro and in vivo.
Zhu H; You J; Wen Y; Jia L; Gao F; Ganesan K; Chen J
J Ethnopharmacol; 2021 Nov; 280():114415. PubMed ID: 34271113
[TBL] [Abstract][Full Text] [Related]
12. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
[TBL] [Abstract][Full Text] [Related]
13. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial.
Hirata JD; Swiersz LM; Zell B; Small R; Ettinger B
Fertil Steril; 1997 Dec; 68(6):981-6. PubMed ID: 9418683
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
16. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells.
Bodinet C; Freudenstein J
Breast Cancer Res Treat; 2002 Nov; 76(1):1-10. PubMed ID: 12408370
[TBL] [Abstract][Full Text] [Related]
17. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R; Webster L
Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
19. Gynaecomastia and the herbal tonic "Dong Quai".
Goh SY; Loh KC
Singapore Med J; 2001 Mar; 42(3):115-6. PubMed ID: 11405562
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling reveals effects of Cimicifuga racemosa (L.) NUTT. (black cohosh) on the estrogen receptor positive human breast cancer cell line MCF-7.
Gaube F; Wolfl S; Pusch L; Kroll TC; Hamburger M
BMC Pharmacol; 2007 Sep; 7():11. PubMed ID: 17880733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
